GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Acadia Pharmaceuticals Inc. (ACAD) [hlAlert]

Rating:
Buy ACAD
up 484.12 %

Acadia Pharmaceuticals Inc. (ACAD) rated Buy by Jefferies

Posted on: Tuesday,  Mar 19, 2013  8:25 AM ET by Jefferies

Jefferies rated Buy Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) on 03/19/2013, when the stock price was $6.49. Since
then, Acadia Pharmaceuticals Inc. has gained 484.13% as of 01/25/2016's recent price of $37.91.
If you would have followed this Jefferies's recommendation on ACAD, you would have gained 484.12% of your investment in 1042 days.

Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders. The Company is developing a portfolio consisting of its four product candidates, including pimavanserin, which is in Phase III development for the treatment of Parkinson?s disease psychosis. In addition, the Company has a product candidate in Phase II for chronic pain and a product candidate in Phase I for glaucoma, both in collaboration with Allergan, Inc., and ACP-106 in IND-track development. The Company?s product candidates include Pimavanserin, AGN-XX/YY, AC-262271 and ACP-106. The Company maintains two wholly owned subsidiaries: ACADIA Pharmaceuticals AB based in Malmo, Sweden and ACADIA Pharmaceuticals A/S based in Denmark.

Jefferiess' research efforts cover U.S. & International equity, high yield, convertibles, derivatives and option strategies, investment grade fixed income, post-reorganization securities, as well as special situations and quantitative research. Our team of more than 150 research professionals covers nearly 1,200 companies in more than 40 industries worldwide. Our analysts focus on identifying emerging industry themes while providing in-depth, thought provoking, objective research.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/19/2013 8:25 AM Buy
None
6.49
as of 12/13/2013
1 Week down  -5.57 %
1 Month up  0.21 %
3 Months down  -0.38 %
1 YTD up  254.85 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy